Abram Scientific, a medical device company focused on advancing next-generation coagulation diagnostics, today announced the closing of a $11.75 million Series A financing round. The round was led by ...
The new funding will accelerate the development of a portable diagnostic platform to enhance care for bleeding disorders and critical care medicine.